A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer

This study is ongoing, but not recruiting participants.

Study NCT00663832 Information provided by Novartis

First Received: April 18, 2008 Last Updated: October 7, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2009 (Final data collection date for primary outcome measure)